EV-301: Phase Ill study to evaluate enfortumab vedotin (EV) versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (Ia/mUC) Meeting Abstract
| Authors: | Petrylak, D. P.; Rosenberg, J. E.; Duran, I.; Loriot, Y.; Sonpavde, G.; Wu, C.; Gartner, E. M.; Melhem-Bertrandt, A.; Powles, T. |
| Abstract Title: | EV-301: Phase Ill study to evaluate enfortumab vedotin (EV) versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (Ia/mUC) |
| Meeting Title: | 2019 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2019 Feb 14-16 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-01 |
| Language: | English |
| ACCESSION: | WOS:000489108800030 |
| DOI: | 10.1200/JCO.2019.37.7_suppl.TPS497 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS497 -- Source: Wos |
